ArticleGeroScience2026
Neural contributions to age-related handgrip weakness revealed by multi-finger force deficit and dual-task testing.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Handgrip strength (HGS) is recognized as the primary characteristic of sarcopenia. Low HGS is strongly associated with morbidity, disability, and mortality. However, the neural mechanisms underlying age-related declines in HGS have not been fully elucidated. The multi-finger force deficit (MFFD), which reflects the central nervous system's capacity to coordinate finger activation during a power grip, provides an innovative approach to assess these neural contributions. Prior MFFD studies have inferred neural contributions to grip force, but this assumes that multi-finger dynamometry captures coordination processes relevant to conventional HGS. Because prior paradigms used non-standard hand/forearm postures and generally studied younger-old, high-functioning adults, the clinical relevance of MFFD to age-related weakness remains uncertain. Therefore, we tested younger (n = 12; 23.7 ± 1.7 years) and markedly older (n = 10; 80.3 ± 8.8 years) adults using a biomimetic setup that replicated traditional HGS assessment and examined whether HGS is altered under cognitively demanding dual-task conditions. Older adults exhibited 48.8% lower HGS, greater MFFD (25.8 ± 11.4% vs. 16.5 ± 7.1%; p < 0.05), and lower performance on HGS during continuous reading aloud than younger adults (17.7 ± 6.7 kg vs. 29.8 ± 9.2 kg; p < 0.001). Further, sarcopenic older adults exhibited a higher MFFD compared to their non-sarcopenic counterparts (33.4 ± 8.6% vs. 18.0 ± 8.3%; p = 0.021), when data are pooled across hands. These findings suggest that age-related reductions in HGS are partly attributable to neural mechanisms. The MFFD may represent a candidate behavioral marker of multi-digit reserve, but its predictive and clinical utility require validation.
Indexed as
Identifiers
42711555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.